Variant report
Variant | nsv8060 |
---|---|
Chromosome Location | chr7:15229228-15236829 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr7:15226823..15229745-chr7:16458349..16461149,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000214960 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs533681141 | chr7:15229242-15229243 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs541048452 | chr7:15229257-15229258 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs189544196 | chr7:15229274-15229275 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs563755791 | chr7:15229279-15229280 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs370733270 | chr7:15229305-15229306 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs139212725 | chr7:15229319-15229320 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs549271932 | chr7:15229333-15229334 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs6944932 | chr7:15229374-15229375 | Inactive region | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs142412050 | chr7:15229378-15229379 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs6965149 | chr7:15229381-15229382 | Inactive region | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs543934985 | chr7:15229396-15229397 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs75097077 | chr7:15229402-15229403 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs143030125 | chr7:15229430-15229431 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs536973744 | chr7:15229435-15229436 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs200310328 | chr7:15229436-15229437 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs529298933 | chr7:15229466-15229467 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs531424830 | chr7:15229515-15229516 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs573795274 | chr7:15229517-15229518 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs6965413 | chr7:15229545-15229546 | Inactive region | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs181601594 | chr7:15229637-15229638 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs561633803 | chr7:15229645-15229646 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs6945452 | chr7:15229699-15229700 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs568891263 | chr7:15229711-15229712 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs190284752 | chr7:15229722-15229723 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs184659675 | chr7:15234413-15234414 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs189421082 | chr7:15234468-15234469 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs182077341 | chr7:15234469-15234470 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs548987030 | chr7:15234471-15234472 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs536301588 | chr7:15234489-15234490 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs137909679 | chr7:15234512-15234513 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs534648876 | chr7:15234524-15234525 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs115306725 | chr7:15234535-15234536 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs112286124 | chr7:15234568-15234569 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs62448917 | chr7:15234571-15234572 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs116851563 | chr7:15234573-15234574 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs142343843 | chr7:15234582-15234583 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs145980248 | chr7:15234588-15234589 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs542730923 | chr7:15234640-15234641 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs185760549 | chr7:15234664-15234665 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs56210830 | chr7:15234671-15234672 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs114800878 | chr7:15234672-15234673 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs115805557 | chr7:15234674-15234675 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs541399260 | chr7:15234690-15234691 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs572110425 | chr7:15234692-15234693 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs10237122 | chr7:15234715-15234716 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs557692694 | chr7:15234765-15234766 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs73275387 | chr7:15234792-15234793 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs191065877 | chr7:15234794-15234795 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs563696233 | chr7:15234799-15234800 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs370541111 | chr7:15234851-15234852 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Biliary cancer | 19435499 | CNVD |
Cancer | 16751803 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Wilms tumour | 21544195 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Glioma | 21971842 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Oral cancer | 21386901 | CNVD |
colon cancer | 17210682 | CNVD |
Lung adenocarcinoma | 21810691 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Hypothalamic hamartomas | 18252217 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Leukemia | 23979775 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Autism | 22495311 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Melanoma | 17363583 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 19242612 | CNVD |
Autism | 18414403 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 21858162 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Cancer | 21637783 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16397240 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Heart disease | 21282601 | CNVD |
Rubinstein-Taybi syndrome | 22470819 | CNVD |
Alzheimer''s disease | 22166940 | CNVD |
Abnormal phenotypes | 18644119 | CNVD |
Non-syndromic sensorineural hearing loss | 22570644 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:15234400-15234600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
2 | chr7:15234400-15235200 | Enhancers | H9 Cell Line | embryonic stem cell |
3 | chr7:15234600-15234800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
4 | chr7:15234600-15236200 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
5 | chr7:15235000-15236200 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
6 | chr7:15235000-15237200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
7 | chr7:15235200-15235600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
8 | chr7:15236000-15236400 | Active TSS | iPS-20b Cell Line | embryonic stem cell |
9 | chr7:15236200-15236800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
10 | chr7:15236200-15238600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
11 | chr7:15236200-15238600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
12 | chr7:15236400-15236600 | Flanking Active TSS | iPS-20b Cell Line | embryonic stem cell |
13 | chr7:15236400-15237000 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
14 | chr7:15236600-15237200 | Enhancers | H1 Cell Line | embryonic stem cell |
15 | chr7:15236600-15237200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
16 | chr7:15236600-15238800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
17 | chr7:15236800-15237200 | Enhancers | Pancreatic Islets | Pancreatic Islet |
18 | chr7:15236800-15238000 | Weak transcription | HUES64 Cell Line | embryonic stem cell |